Business Context and Reporting Period
This Form 8-K Current Report was filed by Neuralstem, Inc. on July 28, 2017, regarding events occurring on July 26 and July 27, 2017. The filing discloses the entry into a Material Definitive Agreement for an underwritten public offering of common stock and warrants.
Key Financial Metrics and Transaction Details
- Offering Structure: Sale of 3,000,000 shares of Common Stock and warrants to purchase 2,250,000 shares of Common Stock.
- Public Offering Price: $2.00 per unit (one share and one warrant).
- Underwriter Price: $1.88 per unit (representing a 6.0% discount).
- Expected Gross Proceeds: $6.0 million.
- Expected Net Proceeds: Approximately $5.4 million (after underwriting discounts, commissions, and estimated offering expenses, assuming no warrant exercise).
- Warrant Terms: Initial exercise price of $2.00; exercisable immediately; expire 7 years from issuance (expected August 1, 2017).
- Underwriter: Canaccord Genuity Inc. (sole book-runner).
Material Changes and Transaction Terms
The primary material change is the execution of the Underwriting Agreement on July 27, 2017. Key terms include:
- Separability: Shares and Warrants are immediately separable.
- Listing Status: Warrants will not be listed on The Nasdaq Capital Market or any other securities exchange.
- Adjustments: Warrant exercise prices are subject to adjustment for stock dividends, splits, and sales of common stock below the exercise price.
- Fundamental Transactions: In the event of a merger or sale of assets, holders may elect to receive cash equal to the warrant value calculated via the Black-Scholes model.
- Beneficial Ownership Limitation: Warrants cannot be exercised if the holder would own more than 4.99% of outstanding shares (electable increase to 9.99% with notice).
- Cashless Exercise: If a registration statement is not effective, warrants may be exercised on a cashless basis.
Outlook, Risks, and Management Commentary
The Company expects to close the Offering on or about August 1, 2017, subject to customary closing conditions. The filing contains forward-looking statements regarding the anticipated closing and net proceeds. Risks include the Company's ability to satisfy closing conditions on a timely basis or at all. The Underwriting Agreement representations were made solely for the benefit of the parties to the agreement and are qualified by confidential disclosures exchanged between them.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received, as the $5.4 million figure is an estimate.
- Confirm the effective date of the Registration Statement on Form S-3 (No. 333-218608) and the filing of the final prospectus supplement.
- Review the specific terms of the Warrants in Exhibit 4.01 regarding cashless exercise mechanics and beneficial ownership limitations.
- Monitor for any fundamental transactions that could trigger the Black-Scholes cash payout provision for warrant holders.
- Check subsequent filings for any changes in the Company's capital structure resulting from this offering.